NMNAT2 and tauopathy: Interestingly, it has recently been reported that the progression of Alzheimer's disease in the APPswe/PS1dE9 transgenic mouse model and in a mouse model of tauopathy correlates with a decrease in Nmnat2 expression [7], [17].